Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection
Pediatric Infectious Disease Journal - United States
doi 10.1097/inf.0000000000002392
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)